Company News

Share this article:
IMS Health launched Ask IMS, a web-based service offering low-cost, entry level strategic market intelligence to newer biopharma firms and startups. The offering, says IMS, provides country specific data on sales and prescribing trends, primary disease treatments and promotion activities in specific markets.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.